FDA Warns Neogen After Contaminated ‘Sterile’ Horse Product Linked to Dozens of Deaths
FDA warned Neogen after HYCOAT, sold as sterile, was tied to fungal infections and horse deaths. Nearly 100 cases; at least 20 euthanized.
/ 490 items
#XY Event-Driven Stocks↓
Invivyd’s LIBERTY Win Wasn’t Enough to Hold the Rally
VYD2311 looked better tolerated than Comirnaty, but combo stats were mixed. Shorts, profit-taking, and a crowded COVID market weighed on IVVD.
Novo Pays Up to $2.6 Billion for a Once-Weekly Weight-Loss Pill
The deal adds HRS-1596 to Novo’s pipeline as Lilly, daily pills and other oral GLP-1s intensify competition in obesity and diabetes.
Iovance Raises 2026 Revenue Guidance Above Street as Amtagvi Demand Holds Up
Iovance lifts 2026 revenue guidance to $410–$420 million on strong Amtagvi demand, beating most Street estimates.
uniQure Shares Slump as AMT-130 Benefit Looks Weaker at Four Years
AMT-130 slowed Huntington’s 44% at four years, but the result lost statistical significance after stronger three-year data. Stock falls as FDA review begins.
AstraZeneca Bets $2 Billion on Summit’s Dual-Target Cancer Drug
Summit and AstraZeneca will co-develop ivonescimab combinations, starting with GI cancers. Each company keeps rights to its own medicines.